Q-Med AB: Invitation to Capital Markets Day

Q-Med AB: Invitation to Capital Markets Day

Q-Med invites analysts, investors and media to Capital Markets Day on May 8 at 
Q-Med in Uppsala.

When:  	
Thursday, May 8, 2008 at 10.00 a.m. CET.

Where:	
Q-Med´s head office, Fyrisvallsgatan 7, Uppsala, Sweden

To attend:	
Contact Camilla Schartau, c.schartau@q-med.com or call 
+46 (0)18 489 1422, no later than May 6.


Q-Med participants: 	
Bengt Ågerup, President and CEO
Alexander Kotsinas, Vice President and CFO
Tommy Gullbo, Vice President Strategic Marketing
Madelene Sandgren, Director Investor Relations and Corporate Communications


Program:      Can be downloaded from www.q-med.com	

Queries should be addressed to: 
Madelene Sandgren, Director Investor Relations and Corporate Communications,
Tel: + 46 (0)70 974 90 15

Q-Med AB is a rapidly growing and profitable biotechnology/medical device
company. The company develops, manufactures, markets, and sells primarily
medical implants. The majority of the products are based on the company's
patented technology, NASHA™, for the production of stabilized non-animal
hyaluronic acid. The product portfolio today contains: Restylane® for filling
lines and folds, contouring and creating volume in the face, Macrolane™ for body
contouring, Durolane™ for the treatment of osteoarthritis of the hip and knee
joints, Deflux® for the treatment of vesicoureteral reflux, VUR, (a malformation
of the urinary bladder) in children, and Solesta™ for the treatment of fecal
incontinence. Sales are made through the company's own subsidiaries or
distributors in over 70 countries. Q Med today has just over 700 coworkers, with
close to 500 at the company's head office and production facility in Uppsala,
Sweden. Q-Med AB is listed in the Mid Cap segment of the OMX Nordic Exchange in
Stockholm.


Q-Med AB (publ), Seminariegatan 21, SE-752 28 Uppsala, Sweden. Corporate
identity number 556258-6882.
Tel: +46(0)18-474 90 00. Fax: +46(0)18-474 90 01. E-mail: info@q-med.com. Web:
www.q-med.com.

In USA, Q-Med AB's affiliate is the wholly-owned subsidiary Q-Med Scandinavia,
Inc.